Single-Dose Study to Evaluate the Pharmacokinetics, Safety, and Tolerability of Pevifoscorvir Sodium (ALG-000184) in Subjects With Moderate Hepatic Impairment and in Healthy Subjects With Normal Hepatic Function
Clinical trial NCT07342868 · RECRUITING
Trial details
- NCT number
- NCT07342868
- Sponsor
- Aligos Therapeutics
- Status
- RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2026-01-30
- Primary completion
- 2026-04-20
- Enrollment
- 16
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.